心血管危险

cardiovascular disease───[内科]心血管疾病；冠心病

cardiovascular fitness───心血管适应能力

cardiovascular system───[解剖]心血管系统

cardiovascular───adj.[解剖]心血管的

cardiovascular conditioning───心血管调节

cardiac arrest───心搏停止

cerebrovascular accident───[内科]脑血管意外（等于中风）；脑血管伤害

avascularity───n.无血管

cardiac arrests───心跳停止；心搏停止

Step 1: Calculate your cardiovascular risk points.───一步：计算你的心血管风险分数。

Check and control your cardiovascular risk.───检查并控制你的心血管疾病风险。

Physical exercise and reducing cardiovascular risk factors have the strongest evidence.───体育锻炼和减少心血管疾病的危险因素对防止阿尔茨海默氏症具有最强有力的证据。

Thus, gum infections seem to add to the inflammatory burden on individuals, increasing cardiovascular risk, the researchers say.───因此，牙龈感染似乎增加了个体的炎性负荷，增加了心血管疾病的发生危险。

For tea, the association between consumption and cerebral infarction also did not vary significantly by age or cardiovascular risk factors.───对茶来说，摄取量和脑梗塞之间的关联同样并没有因年龄或心血管风险因素而改变。

The ADMA plasma level also tended to increase with an increasing number of classic cardiovascular risk factors, the researchers note.───研究者还注意到：ADMA血浆水平倾向于随着传统的心血管风险因子种类的增加而增加。

Individuals found to have prediabetes should be evaluated and treated, if appropriate, for other cardiovascular risk factors (B).───个人发现有糖尿病前期应当评价和处理，如果合适，应对其他心血管危险因素应当评价和处理（B）。

So just like anybody who has cardiovascular risk, low cholesterol and low saturated fat should be a major part of the diet.───如心血管高危患者一样，食物应当低胆固醇和低饱和脂肪酸。

CONCLUSIONS Weight reduction with GLP-1 receptor agonists was associated with a shift toward a more favorable cardiovascular risk profile.───结论：GLP-1受体激动剂治疗后的体重减轻与心血管危险因素谱向更有益的方向转变有关。

Probably mainly for patients with very high cardiovascular risk, for instance those patients with cardiovascular disease and with target organ damage.

ACCORD Lipid confirms both the hypothesis and the value of adding fenofibrate to a statin to reduce this high residual cardiovascular risk.

Objective To determine serum true insulin (TI) and proinsulin (PI) levels in patients with coronary heart disease (CHD), and to explore the relationships of them to other cardiovascular risk factors.

The goal of this statement was to develop evidence-based EULAR recommendations for cardiovascular risk management in patients with RA, ankylosing spondylitis, and psoriatic arthritis.

Cardiovascular risk needs to be taken into account when prescribing any non-steroidal anti-inflammatory drug.

Individuals found to have prediabetes should be evaluated and treated, if appropriate, for other cardiovascular risk factors (B).

The increased cardiovascular risk compared with placebo was reported in a 2004 analysis of the adenomatous polyp prevention on Vioxx (APPROVe) study, w13 which led to the drug's withdrawal.

The effect of cyclooxygenase-2 inhibitors and most nonsteroidal anti-inflammatory drugs (NSAIDs) on cardiovascular risk is not completely determined and should be studied further.

The current recommended diabetic dietary regimen appears to result in a reduction in lipid cardiovascular risk.